Recent News

• 04.02.2025 - Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome
• 04.02.2025 - Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome
• 03.24.2025 - Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates
• 03.24.2025 - Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates
• 03.19.2025 - Stifel Virtual CNS Forum
• 03.19.2025 - Stifel Virtual CNS Forum
• 03.10.2025 - Leerink Global Healthcare Conference
• 03.10.2025 - Leerink Global Healthcare Conference

Recent Filings

• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - EFFECT Notice of Effectiveness
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.24.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.24.2025 - S-3 Registration statement under Securities Act of 1933
• 03.24.2025 - 8-K Current report
• 03.24.2025 - EX-99.1 EX-99.1